Johnson Financial Group Inc (Wisconsin)’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.8K Sell
125
-125
-50% -$21.5K ﹤0.01% 546
2026
Q1
$42.2K Hold
250
﹤0.01% 496
2025
Q4
$42.2K Hold
250
﹤0.01% 524
2025
Q3
$36.1K Hold
250
﹤0.01% 653
2025
Q2
$31.6K Sell
250
-10
-4% -$1.23K ﹤0.01% 498
2025
Q1
$33.3K Buy
260
+10
+4% +$1.36K ﹤0.01% 677
2024
Q4
$34.7K Hold
250
﹤0.01% 544
2024
Q3
$36.4K Buy
+250
New +$36.2K ﹤0.01% 554
2023
Q4
Sell
-1,000
Closed -$122K 963
2023
Q3
$122K Hold
1,000
0.01% 290
2023
Q2
$127K Hold
1,000
0.01% 311
2023
Q1
$129K Sell
1,000
-1,835
-65% -$240K 0.01% 312
2022
Q4
$372K Buy
2,835
+2,000
+240% +$258K 0.03% 192
2022
Q3
$98K Hold
835
0.01% 296
2022
Q2
$98K Buy
835
+35
+4% +$4.16K 0.01% 322
2022
Q1
$104K Buy
800
+500
+167% +$65.1K 0.01% 348
2021
Q4
$46K Buy
+300
New +$46.4K ﹤0.01% 458
2021
Q2
Sell
-63
Closed -$9K 779
2021
Q1
$9K Buy
+63
New +$10K ﹤0.01% 555
2018
Q1
Sell
-450
Closed -$48K 580
2017
Q4
$48K Buy
+450
New +$48.1K 0.01% 364

Other funds holding IBB

Johnson Financial Group Inc (Wisconsin)'s IBB Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) reduced its iShares Biotechnology ETF (IBB) stake by 50% in Q2 2026, selling an estimated $21.5K and leaving 125 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #546.

Johnson Financial Group Inc (Wisconsin) first reported a position in IBB in Q4 2017 and has held it in 18 quarters since. The position peaked at $372K in Q4 2022. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Johnson Financial Group Inc (Wisconsin) held 125 shares of iShares Biotechnology ETF worth $23.8K as of Q2 2026.
  • Johnson Financial Group Inc (Wisconsin) sold 125 iShares Biotechnology ETF shares in Q2 2026, an estimated $21.5K.
  • iShares Biotechnology ETF made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #546 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 18 quarters since.
  • Johnson Financial Group Inc (Wisconsin)'s iShares Biotechnology ETF position peaked at $372K in Q4 2022.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.